ClinicalTrials.gg
RecruitingNCT06691087ETERNELUpdated Mar 31, 2026

Sound Perception Study of Hearing-impaired People With Hearing Aids

An interventional study of Influence of the parameters of the sound timbre on the perception of a sound and Complex sound scene comprehension test in Auditory Perception, sponsored by Institut Pasteur. Recruiting at 1 site in France. Open to participants aged 60 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-31.

Sponsored by Institut Pasteur · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Apr 2025; still recruiting 1 year 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Non-randomized
Ages
60 Years to 75 Years
Sex
All
01

Study summary

The aim of the ETERNEL project will be to study the influence of the perception of a single sound timbre on the understanding of a complex sound scene in hearing-impaired people with hearing aids. This will be done by quantifying the inability to manage a complex sound scene as a function of the timbre of the sounds making it up. The more a sound interferes with understanding the complex sound scene, the more salient that sound is considered to be. In this way, the investigators can determine which timbre dimensions make sounds particularly salient for the hearing impaired.

02

Conditions studied

  • Auditory Perception
03

In context

Lead sponsor

Institut Pasteur is the lead sponsor of 99 studies on the registry; 41 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

For all participants:

  • Age between 60 and 75
  • Native French speaker
  • Have given their consent to take part in the study.
  • Declare that they have an active social life or hobbies that stimulate their cognitive abilities
  • Have a MOCA score above 26
  • No tympano-ossicular dysfunction.
  • Voice in noise audiometry results showing normal results.

For participants with impaired hearing :

  • Pure tone audiometry showing audiograms of type N3 or N4 and symmetrical between the two ears.
  • Report having experienced problems with abnormally prominent sound.

For participants with normal hearing:

- Pure tone audiometry showing audiograms with losses of less than 30 dBHl.

Exclusion criteria

Exclusion Criteria:

  • Be under guardianship or curatorship,
  • Be deprived of liberty by judicial or administrative decision, or be under legal protection.
  • Bear the consequences of an ear infection and/or have a history of an ENT disease that permanently affects hearing or balance (vestibular schwannoma, Ménière's disease, sudden or fluctuating deafness, congenital hypoacusis).
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
75 participants (estimated)

Study arms

  • Active comparator
    Normal Hearing participants

    Behavioral: Influence of the parameters of the sound timbre on the perception of a sound · Behavioral: Complex sound scene comprehension test

  • Experimental
    Hearing-impaired with hearing aids

    Behavioral: Influence of the parameters of the sound timbre on the perception of a sound · Behavioral: Complex sound scene comprehension test · Behavioral: Complex sound scene comprehension test with hearing aids

Interventions

  • BehavioralInfluence of the parameters of the sound timbre on the perception of a sound

    The experiment consists of evaluating the sound level of n complex stimuli, then equalising them in loudness, in order to measure a loudness curve in function of timbre descriptors. The stimuli will then be listened to again in pairs. The task is there to compare the stimuli using a VAS to indicate how different the two sounds are.

  • BehavioralComplex sound scene comprehension test

    The experiment consists in identifying the parameters of the sound timbre that most disturb the understanding of complex sound scenes, by asking the participants to identify sounds whose timbre has been modified.

  • BehavioralComplex sound scene comprehension test with hearing aids

    The experiment will be identical to intervention 2. This time, the modification of the stimulus timbres will focus on the most problematic dimensional modifications, i.e. those where the difference between normal-hearing and hearing-impaired listeners is greatest. We will then modify the signal processing parameters of the hearing aid simulator (for example, the size of the averaging window or the gain balance of the filters), to observe their impact on the salience of certain stimuli.

06

What researchers measure

Primary outcomes

  1. Percentage of correct answers in melody comparison tasks in the hearing-impaired group compared with the normal-hearing group,

    Time frame: 3-hours

Secondary outcomes

  1. Characterisation of the dissimilarity between pairs of stimuli measured by a continuous perceptual scale

    Continuous perceptual scale ranging from very dissimilar to very similar

    Time frame: 3-hours

  2. Evaluation of the perceived loudness level of a set of stimuli, measured using scales of magnitude.

    11-point Likert scale

    Time frame: 3-hours

  3. Comparison between the results of speech audiometry in noise, i.e number of words correctly repeated, with native settings versus settings minimising the discomfort of salient sounds for each participant with hearing loss.

    the comparison will focus on the number of words correctly repeated on the 1st visit (with native settings) versus the last visit (with settings minimising the discomfort)

    Time frame: up to 24 months

07

Study locations

1 of 1 sites recruiting
  • CeRIAH
    Paris, France
    Recruiting
    • Paul Avan · Contact
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2025 (actual). Primary completion is estimated for Nov 2026, 19 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 14, 2024
First posted
Nov 15, 2024
StartActual
Apr 22, 2025
Primary completionEst.
Nov 2026
CompletionEst.
Nov 2028
Last update
Mar 31, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 31, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06691087
Lead sponsor
Institut Pasteur
Collaborators
Institut de l'Audition
Responsible party
Sponsor
First posted
Nov 15, 2024
Start date
Apr 22, 2025
Primary completion
Nov 2026 (estimated)
Completion
Nov 2028 (estimated)
Last update
Mar 31, 2026

Study contacts

Céline Quinsac
Contact
celine.quinsac@pasteur.fr
0176535029 ext. +33
Armand Schwarz
Contact
armand.schwarz@pasteur.fr
Paul Avan
principal investigator · CERIAH

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion